{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:03:17Z","timestamp":1790532197721,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-024-01302-3","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T14:02:07Z","timestamp":1727964127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["SMILES-based QSAR virtual screening to identify potential therapeutics for COVID-19 by targeting 3CLpro and RdRp viral proteins"],"prefix":"10.1186","volume":"18","author":[{"given":"Faezeh","family":"Bazzi-Allahri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Shiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla P.","family":"Toropova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Toropov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"issue":"10","key":"1302_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1021\/acsptsci.3c00127","volume":"6","author":"J Li","year":"2023","unstructured":"Li J, Wang J, Wang H. Emerging landscape of preclinical models for studying COVID-19 neurologic diseases. ACS Pharmacol Transl Sci. 2023;6(10):1323\u201339.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"4","key":"1302_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","volume":"4","author":"MA Farha","year":"2019","unstructured":"Farha MA, Brown ED. Drug repurposing for antimicrobial discovery. Nat Microbiol. 2019;4(4):565\u201377.","journal-title":"Nat Microbiol"},{"issue":"4","key":"1302_CR3","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1021\/acs.jmedchem.0c02258","volume":"65","author":"W Dai","year":"2021","unstructured":"Dai W, Jochmans D, Xie H, Yang H, Li J, Su H, Chang D, Wang J, Peng J, Zhu L. Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-CoV-2. J Med Chem. 2021;65(4):2794\u2013808.","journal-title":"J Med Chem"},{"issue":"5","key":"1302_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. 2020;10(5):766\u201388.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"1","key":"1302_CR5","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","volume":"11","author":"DW Kneller","year":"2020","unstructured":"Kneller DW, Phillips G, O\u2019Neill HM, Jedrzejczak R, Stols L, Langan P, Joachimiak A, Coates L, Kovalevsky A. Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nat Commun. 2020;11(1):3202.","journal-title":"Nat Commun"},{"issue":"6492","key":"1302_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.abb7498","volume":"368","author":"Y Gao","year":"2020","unstructured":"Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, Wang T, Sun Q, Ming Z, Zhang L. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368(6492):779\u201382.","journal-title":"Science"},{"issue":"10","key":"1302_CR7","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.7150\/ijbs.24612","volume":"14","author":"H Xue","year":"2018","unstructured":"Xue H, Li J, Xie H, Wang Y. Review of drug repositioning approaches and resources. Int J Biol Sci. 2018;14(10):1232.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1302_CR8","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3762\/bjoc.12.267","volume":"12","author":"SP Leelananda","year":"2016","unstructured":"Leelananda SP, Lindert S. Computational methods in drug discovery. Beilstein J Org Chem. 2016;12(1):2694\u2013718.","journal-title":"Beilstein J Org Chem"},{"key":"1302_CR9","unstructured":"Hung I. Lopinavir\/ritonavir, ribavirin and IFN-beta combination for nCoV treatment. NCT04276688. 2020."},{"key":"1302_CR10","unstructured":"USNLo M. A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19. ClinicalTrialsgov. 2020."},{"issue":"10236","key":"1302_CR11","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236):1569\u201378.","journal-title":"Lancet"},{"key":"1302_CR12","unstructured":"Polo R, Hern\u00e1n M. Randomized clinical trial for the prevention of SARS-CoV-2 infection (COVID-19) in healthcare personnel (EPICOS). ClinicalTrials. gov; 2020."},{"issue":"4","key":"1302_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/cells9040920","volume":"9","author":"Z Wang","year":"2020","unstructured":"Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells. 2020;9(4):920.","journal-title":"Cells"},{"key":"1302_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijid.2020.05.085","volume":"97","author":"S De Meyer","year":"2020","unstructured":"De Meyer S, Bojkova D, Cinatl J, Van Damme E, Buyck C, Van Loock M, Woodfall B, Ciesek S. Lack of antiviral activity of darunavir against SARS-CoV-2. Int J Infect Dis. 2020;97:7\u201310.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"1302_CR15","first-page":"3390","volume":"24","author":"X-T Ye","year":"2020","unstructured":"Ye X-T, Luo Y-L, Xia S-C, Sun Q-F, Ding J-G, Zhou Y, Chen W, Wang X-F, Zhang W-W, Du W-J. Clinical efficacy of lopinavir\/ritonavir in the treatment of Coronavirus disease 2019. Eur Rev Med Pharmacol Sci. 2020;24(6):3390\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1302_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.12688\/f1000research.22457.2","volume":"9","author":"YW Chen","year":"2020","unstructured":"Chen YW, Yiu CPB, Wong K-Y. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research. 2020;9:129.","journal-title":"F1000Research"},{"key":"1302_CR17","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202003.0302.v1","volume-title":"Focusing on the unfolded protein response and autophagy related pathways to reposition common approved drugs against COVID-19","author":"S Nabirotchkin","year":"2020","unstructured":"Nabirotchkin S, Peluffo AE, Bouaziz J, Cohen D. Focusing on the unfolded protein response and autophagy related pathways to reposition common approved drugs against COVID-19. Basel: MDPI AG; 2020."},{"key":"1302_CR18","first-page":"399","volume":"9","author":"F Verdugo-Paiva","year":"2020","unstructured":"Verdugo-Paiva F, Izcovich A, Ragusa M, Rada G. C.-L.-OW Group, Lopinavir\/ritonavir for the treatment of COVID-19: a living systematic review protocol. medRxiv. 2020;9:399.","journal-title":"medRxiv"},{"issue":"3","key":"1302_CR19","doi-asserted-by":"publisher","first-page":"100061","DOI":"10.1016\/j.infpip.2020.100061","volume":"2","author":"M Tobaiqy","year":"2020","unstructured":"Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, Helmi N. Therapeutic management of patients with COVID-19: a systematic review. Infect Prevent Pract. 2020;2(3):100061.","journal-title":"Infect Prevent Pract"},{"issue":"3","key":"1302_CR20","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/med.21764","volume":"41","author":"S Vatansever","year":"2021","unstructured":"Vatansever S, Schlessinger A, Wacker D, Kaniskan H\u00dc, Jin J, Zhou MM, Zhang B. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: state-of-the-arts and future directions. Med Res Rev. 2021;41(3):1427\u201373.","journal-title":"Med Res Rev"},{"issue":"1","key":"1302_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1062936X.2016.1264468","volume":"28","author":"V Prachayasittikul","year":"2017","unstructured":"Prachayasittikul V, Worachartcheewan A, Toropova A, Toropov A, Schaduangrat N, Prachayasittikul V, Nantasenamat C. Large-scale classification of P-glycoprotein inhibitors using SMILES-based descriptors. SAR QSAR Environ Res. 2017;28(1):1\u201316.","journal-title":"SAR QSAR Environ Res"},{"issue":"1","key":"1302_CR22","doi-asserted-by":"publisher","first-page":"16771","DOI":"10.1038\/s41598-020-73681-1","volume":"10","author":"LK Tsou","year":"2020","unstructured":"Tsou LK, Yeh S-H, Ueng S-H, Chang C-P, Song J-S, Wu M-H, Chang H-F, Chen S-R, Shih C, Chen C-T. Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery. Sci Rep. 2020;10(1):16771.","journal-title":"Sci Rep"},{"issue":"8","key":"1302_CR23","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.drudis.2018.05.010","volume":"23","author":"Y-C Lo","year":"2018","unstructured":"Lo Y-C, Rensi SE, Torng W, Altman RB. Machine learning in chemoinformatics and drug discovery. Drug Discov Today. 2018;23(8):1538\u201346.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1302_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10799893.2017.1414844","volume":"38","author":"F Shiri","year":"2018","unstructured":"Shiri F, Pirhadi S, Rahmani A. Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening. J Recept Signal Transduct. 2018;38(1):37\u201347.","journal-title":"J Recept Signal Transduct"},{"key":"1302_CR25","doi-asserted-by":"publisher","first-page":"103459","DOI":"10.1016\/j.etap.2020.103459","volume":"80","author":"CI Cappelli","year":"2020","unstructured":"Cappelli CI, Toropov AA, Toropova AP, Benfenati E. Ecosystem ecology: Models for acute toxicity of pesticides towards Daphnia magna. Environ Toxicol Pharmacol. 2020;80:103459.","journal-title":"Environ Toxicol Pharmacol"},{"key":"1302_CR26","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s11224-020-01568-y","volume":"31","author":"S Lotfi","year":"2020","unstructured":"Lotfi S, Ahmadi S, Zohrabi P. QSAR modeling of toxicities of ionic liquids toward Staphylococcus aureus using SMILES and graph invariants. Struct Chem. 2020;31:2257\u201370.","journal-title":"Struct Chem"},{"issue":"2","key":"1302_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/toxsci\/kfw125","volume":"153","author":"S Manganelli","year":"2016","unstructured":"Manganelli S, Benfenati E, Manganaro A, Kulkarni S, Barton-Maclaren TS, Honma M. New quantitative structure\u2013activity relationship models improve predictability of Ames mutagenicity for aromatic azo compounds. Toxicol Sci. 2016;153(2):316\u201326.","journal-title":"Toxicol Sci"},{"issue":"42","key":"1302_CR28","doi-asserted-by":"publisher","first-page":"27344","DOI":"10.1021\/acsomega.0c03682","volume":"5","author":"J Ivanov","year":"2020","unstructured":"Ivanov J, Polshakov D, Kato-Weinstein J, Zhou Q, Li Y, Granet R, Garner L, Deng Y, Liu C, Albaiu D. Quantitative structure\u2013activity relationship machine learning models and their applications for identifying viral 3CLpro-and RdRp-targeting compounds as potential therapeutics for COVID-19 and related viral infections. ACS Omega. 2020;5(42):27344\u201358.","journal-title":"ACS Omega"},{"issue":"24","key":"1302_CR29","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.2174\/1568026611212240004","volume":"12","author":"A Toropov","year":"2012","unstructured":"Toropov A, Toropova A, Benfenati E, Gini G, Leszczynska D, Leszczynski J. CORAL: classification model for predictions of anti-sarcoma activity. Curr Top Med Chem. 2012;12(24):2741\u20134.","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"1302_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/157488612804096542","volume":"7","author":"AA Toropov","year":"2012","unstructured":"Toropov AA, Toropova AP, Rasulev BF, Benfenati E, Gini G, Leszczynska D, Leszczynski J. CORAL: binary classifications (active\/inactive) for liver-related adverse effects of drugs. Curr Drug Saf. 2012;7(4):257\u201361.","journal-title":"Curr Drug Saf"},{"key":"1302_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.toxlet.2017.01.011","volume":"268","author":"AP Toropova","year":"2017","unstructured":"Toropova AP, Toropov AA. CORAL: binary classifications (active\/inactive) for drug-induced liver injury. Toxicol Lett. 2017;268:51\u20137.","journal-title":"Toxicol Lett"},{"key":"1302_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.molstruc.2019.01.040","volume":"1182","author":"AP Toropova","year":"2019","unstructured":"Toropova AP, Toropov AA. QSPR and nano-QSPR: what is the difference? J Mol Struct. 2019;1182:141\u20139.","journal-title":"J Mol Struct"},{"key":"1302_CR33","doi-asserted-by":"publisher","first-page":"125192","DOI":"10.1016\/j.chemosphere.2019.125192","volume":"242","author":"S Ahmadi","year":"2020","unstructured":"Ahmadi S. Mathematical modeling of cytotoxicity of metal oxide nanoparticles using the index of ideality correlation criteria. Chemosphere. 2020;242:125192.","journal-title":"Chemosphere"},{"key":"1302_CR34","doi-asserted-by":"publisher","first-page":"116465","DOI":"10.1016\/j.molliq.2021.116465","volume":"338","author":"S Lotfi","year":"2021","unstructured":"Lotfi S, Ahmadi S, Kumar P. A hybrid descriptor based QSPR model to predict the thermal decomposition temperature of imidazolium ionic liquids using Monte Carlo approach. J Mol Liq. 2021;338:116465.","journal-title":"J Mol Liq"},{"key":"1302_CR35","doi-asserted-by":"publisher","first-page":"123777","DOI":"10.1016\/j.jhazmat.2020.123777","volume":"402","author":"A Kumar","year":"2021","unstructured":"Kumar A, Kumar P. Cytotoxicity of quantum dots: Use of quasiSMILES in development of reliable models with index of ideality of correlation and the consensus modelling. J Hazard Mater. 2021;402:123777.","journal-title":"J Hazard Mater"},{"issue":"1","key":"1302_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13065-023-00947-w","volume":"17","author":"N Soleymani","year":"2023","unstructured":"Soleymani N, Ahmadi S, Shiri F, Almasirad A. QSAR and molecular docking studies of isatin and indole derivatives as SARS 3CLpro inhibitors. BMC Chem. 2023;17(1):32.","journal-title":"BMC Chem"},{"key":"1302_CR37","doi-asserted-by":"publisher","first-page":"112580","DOI":"10.1016\/j.fct.2021.112580","volume":"157","author":"AP Toropova","year":"2021","unstructured":"Toropova AP, Toropov AA, Benfenati E. Semi-correlations as a tool to model for skin sensitization. Food Chem Toxicol. 2021;157:112580.","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"1302_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/1062936X.2020.1806922","volume":"31","author":"M Javidfar","year":"2020","unstructured":"Javidfar M, Ahmadi S. QSAR modelling of larvicidal phytocompounds against Aedes aegypti using index of ideality of correlation. SAR QSAR Environ Res. 2020;31(10):717\u201339.","journal-title":"SAR QSAR Environ Res"},{"issue":"2","key":"1302_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/1386207318666141229123705","volume":"18","author":"JB Ghasemi","year":"2015","unstructured":"Ghasemi JB, Shiri F, Pirhadi S, Heidari Z. Discovery of new potential antimalarial compounds using virtual screening of ZINC database. Comb Chem High Throughput Screen. 2015;18(2):227\u201334.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"W1","key":"1302_CR40","doi-asserted-by":"publisher","first-page":"W442","DOI":"10.1093\/nar\/gkw287","volume":"44","author":"J Sunseri","year":"2016","unstructured":"Sunseri J, Koes DR. Pharmit: interactive exploration of chemical space. Nucleic Acids Res. 2016;44(W1):W442\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1302_CR41","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","volume":"53","author":"DR Koes","year":"2013","unstructured":"Koes DR, Baumgartner MP, Camacho CJ. Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model. 2013;53(8):1893\u2013904.","journal-title":"J Chem Inf Model"},{"key":"1302_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open babel: an open chemical toolbox. J Cheminform. 2011;3:1\u201314.","journal-title":"J Cheminform"},{"issue":"11","key":"1302_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.6881","volume":"36","author":"M Hashemizadeh","year":"2022","unstructured":"Hashemizadeh M, Shiri F, Shahraki S, Razmara Z. A multidisciplinary study for investigating the interaction of an iron complex with bovine liver catalase. Appl Organomet Chem. 2022;36(11): e6881.","journal-title":"Appl Organomet Chem"},{"issue":"1","key":"1302_CR44","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.","journal-title":"Sci Rep"},{"issue":"2","key":"1302_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, von Korff M, Rufener C. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model. 2015;55(2):460\u201373.","journal-title":"J Chem Inf Model"},{"key":"1302_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-2-353","volume":"2","author":"F Ntie-Kang","year":"2013","unstructured":"Ntie-Kang F. An in silico evaluation of the ADMET profile of the StreptomeDB database. Springerplus. 2013;2:1\u201311.","journal-title":"Springerplus"},{"key":"1302_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejmech.2014.12.006","volume":"90","author":"D Newby","year":"2015","unstructured":"Newby D, Freitas AA, Ghafourian T. Decision trees to characterise the roles of permeability and solubility on the prediction of oral absorption. Eur J Med Chem. 2015;90:751\u201365.","journal-title":"Eur J Med Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-024-01302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-024-01302-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-024-01302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:04:00Z","timestamp":1727967840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-024-01302-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1186\/s13065-024-01302-3","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}